Eastman Chemical vs ICL
EMN and ICL side by side, both in chemicals and allied products. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How EMN and ICL compare
ICL grew revenue faster over the last twelve months (4.6% versus 0.27% for Eastman Chemical).
Eastman Chemical keeps more of each dollar of sales as profit, with a net margin of 6.9% compared with 3.2% at ICL.
Eastman Chemical pays a dividend yielding 5.2%; ICL does not pay one.
Eastman Chemical scores higher on the StockData Score (16 against 7 for ICL), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | EMN | ICL |
|---|---|---|
| Size and price | ||
| Market cap | $7.4B | – |
| Share price | $65.03 | $4.52 |
| Change, 1 year | 6.7% | −17.8% |
| Change, 5 years | −42.5% | −52.3% |
| Beta (5Y) | 1.10 | 0.74 |
| Employees | 13K | 13K |
| StockData Score | ||
| Total score | 16 (better) | 7 |
| Valuation score | 5 (better) | 0 |
| Growth score | 1 (better) | 0 |
| Performance score | 2 | 3 (better) |
| Health score | 2 | 4 (better) |
| Dividend score | 6 (better) | 0 |
| Valuation | ||
| P/E | 12.0× | – |
| P/S | 0.8× | – |
| P/B | 1.2× | – |
| P/FCF | 15.9× | – |
| FCF yield | 6.3% | – |
| Fair value | $92.79 | – |
| Margin of safety | 29.9% | – |
| Growth | ||
| Revenue growth (TTM) | 0.27% | 4.6% (better) |
| Revenue growth, 5Y average | 0.65% | 7.2% (better) |
| Net income growth (TTM) | −13.3% (better) | −44.5% |
| EPS growth (TTM) | −12.3% (better) | −43.8% |
| EPS growth, 5Y average | 3.2% | 78.3% (better) |
| Profitability | ||
| Gross margin | 20.6% | 30.6% (better) |
| Operating margin | – | 8.1% |
| Net margin | 6.9% (better) | 3.2% |
| FCF margin | 5.2% | – |
| Return on equity | 10.4% (better) | 3.9% |
| Return on invested capital | – | 4.8% |
| Financial health | ||
| Debt / equity | 0.83 | 0.39 (better) |
| Net debt / EBITDA | – | 1.70 |
| Interest coverage | – | 1.9× |
| Current ratio | 1.57 (better) | 1.33 |
| Altman Z-score | 2.13 | – |
| Piotroski F-score | 5 | 5 |
| Dividends and buybacks | ||
| Dividend yield | 5.2% | – |
| Payout ratio | 61.1% | 99.1% |
| Years of dividend growth | 16 | – |
| Dividend growth, 5Y average | 4.5% | – |
| Shareholder yield | 5.2% | – |
| Ownership | ||
| Held by institutions | 94.1% | 15.2% |
| Held by insiders | 0.83% | 0.02% |
| Insider net buying, 12 months | −$206K | – |
| Superinvestors holding | 1 | – |
| Short interest, % of float | 4.9% | 0.29% |
Go deeper
- EMN stock overview
- EMN income statement
- EMN valuation and score
- ICL stock overview
- ICL income statement
- ICL valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.